Aussie8 – Lifestyle
Author:
XVIVO Perfusion AB
XVIVO Presents Encouraging Results From First Clinical Trial Using Hypothermic Oxygenated Perfusion (HOPE) In Direct Procurement DCD Heart Transplantation
April 22, 2026
Preliminary One-Year Follow-up Data From the US Preserve Trial for XVIVO’s Heart Technology Presented at ISHLT in Toronto
April 22, 2026
Conference Call on Interim Report January-March 2026
April 17, 2026
The 12-Month Follow-up Results from XVIVO’s European Multicenter Heart Trial is Now Published in the European Heart Journal
April 16, 2026
Annual Report 2025
April 1, 2026
Notice To Attend the Annual General Meeting in XVIVO Perfusion Ab (Publ)
March 19, 2026